Paratek Pharmaceuticals
PRTK
#9015
Rank
โ‚น11.48 B
Marketcap
โ‚น200.34
Share price
0.00%
Change (1 day)
22.60%
Change (1 year)

Revenue for Paratek Pharmaceuticals (PRTK)

Revenue in 2023 (TTM): โ‚น13.79 Billion

According to Paratek Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น15.06 Billion. In 2022 the company made a revenue of โ‚น12.47 Billion an increase over the revenue in the year 2021 that were of โ‚น9.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Paratek Pharmaceuticals from 2004 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น13.79 B10.59%
2022 โ‚น12.47 B38.6%
2021 โ‚น9.00 B182.87%
2020 โ‚น3.18 B169.77%
2019 โ‚น1.17 B-1.43%
2018 โ‚น1.19 B48.58%
2017 โ‚น0.80 B40776.14%
2016 โ‚น1.97 M
2015 N/A-100%
2014 โ‚น0.27 B154.97%
2013 โ‚น0.10 B-82.12%
2012 โ‚น0.60 B-42.05%
2011 โ‚น1.04 B86%
2010 โ‚น0.56 B131.79%
2009 โ‚น0.24 B-91.71%
2008 โ‚น2.91 B
2005 โ‚น2.52 M-94.8%
2004 โ‚น48.5 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Spectrum Pharmaceuticals
SPPI
โ‚น2.31 B-84.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น9.59 B-36.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น56.65 B 275.93%๐Ÿ‡บ๐Ÿ‡ธ USA